A government-backed report has called on companies, investors and regulators to do more to close the gender equality gap at the very top of the FTSE 350.

Sir Philip Hampton, the chair of pharmaceuticals giant GlaxoSmithKline, and Dame Helen Alexander, the chair of events firm UBM, outlined on November 8 the next steps they believed needed to be taken to increase female representation on the boards of FTSE 350 companies.